Ocutrx Says It Will Deliver World’s First 5G AR/XR Medical Specific Platform in 2021
Ocutrx Vision Technologies announced plans to deliver the first AR headsets specific for medical applications providing connectivity from AT&T and using 5G products from Qualcomm Technologies.
Ocutrx is building its AR/XR medical device, the Oculenz headset, for patient use; and a second headset, the ORLenz, is designed for physicians and surgeons. Both will be built upon the Qualcomm Snapdragon XR2 Platform, which features the Qualcomm Snapdragon X55 5G Modem-RF System.
AT&T will provide IoT solutions, including AT&T Control Center and cellular connectivity for Ocutrx devices – allowing highly secure, near real-time access to data. The cellular connectivity within the headset also provides the ARWear to function as a smartphone.
About Ocutrx ARwear
Ocutrx makes AR/XR headsets for both the patient and health care provider. For patients, the Oculenz AMD provides ground-breaking technology to offer a solution for advanced macular degeneration and other central visual deficits in patients with retinal disease. The Oculenz RMP Remote Medical Presence model is for the remote telemedicine and contains various patient vital sensors including visual-field test, blood pressure, heart rate and blood oxygenation. The Oculenz LVP is for low-vision patients to maneuver around in their environment using SLAM supported by the Snapdragon XR2 Platform. SLAM in the Oculenz headset works much like how autonomous cars drive and can direct someone on a path and audibly advise them when dangers, such as curbs, stop signs or stairs, are near their path. The Oculenz EyAlinz is a device which can help diagnose and treat younger patients with amblyopia (lazy eye) and provide a binocular recovery solution.
For the physician, Ocutrx has developed the ORLenz for surgery visualization, providing a surgery video feed with virtual information superimposed in the view of a surgeon, assistant or students/fellows. There is also an ORLenz version for those who practice interactive radiology to see both the body and a probe at the same time in an AR/XR overlay. These surgery AR/XR headsets are also featured in the Ocutrx OR-Bot Surgery Visualization Theatre, which spotlight three fully 4k viewing methods for surgeons to see ophthalmic, spinal, EMT, vascular, neural or coronary surgeries.
Dr. Daniel Ting, MD, PhD, a Chief Medical AI Advisor to Ocutrx and a leading global ophthalmology AI expert is working with Ocutrx to develop an Ophthalmology AI platform for ophthalmic surgeries. The ORLenz AI will access a HIPAA-secured cloud and can analyze thousands of surgeries. It will notify the surgeon of optimal scenarios and times during surgery for where to perform membrane peeling, laser, injections or other actions to prevent injury to the operating tissue and to improve patient outcomes.
“The ORLenz AI engine will enhance surgeries with information presented as virtual markers on the ORLenz headset lens,” says Dr. Ting, “In addition to the surgery video feed, there will be blinking cursors, menus and text shown during the surgery viewable virtually by the surgeon on the AR headset.”
Dr. Linda Lam, MD, MBA, Ocutrx Chief Medical Officer, highlighted that the results can be accessed remotely for later review and analysis by the healthcare provider, allowing for telemonitoring and telemedicine capabilities and services.
